Bioinks and 3D printed organs the focus of new CollPlant division

CollPlant, developer of plant-based rhCollagen technology for tissue repair, will be expanding its research into bioprinting organs and other tissues.

May 15, 2017

Research into collagen-based bioinks will be the focus of a new division established by CollPlant (Israel). The inks are intended to be utilized in the production of 3D printed organs and other tissues. CollPlant’s proprietary rhCollagen technology utilizes genetically engineered tobacco plants to grow collagen tissues identical to the type I collagen produced by the human body. It is hoped this artificial collagecould offer a solution to tissue regeneration and repair.

Read the full story on 3DMedNet

Freya Leask

Publisher, Future Science Group

I am the Publisher of RegMedNet, 3DMedNet, RxNet and The Evidence Base, here to help users make the most of the websites and build our expert communities. I am passionate about digital and STM publishing, social media and story-telling. Please get in touch if you have any queries or comments!

No comments yet.